$8.48
arrow_drop_up1.49%Key Stats | |
---|---|
Open | $8.30 |
Prev. Close | $8.36 |
EPS | 0.87 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
LOW | HIGH | |
---|---|---|
Day Range | 8.11 | 8.60 |
52 Week Range | 6.11 | 16.69 |
Ratios | |
---|---|
EPS | 0.87 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Bragar Eagel & Squire, P.C. Is Investigating Metagenomi, Target Hospitality, Helios, and LegalZoom and Encourages Investors to Contact the Firm
Theratechnologies annoncera ses résultats financiers du deuxième trimestre de l’exercice financier de 2024 et fera une mise à jour de ses activités
Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update
Royal Caribbean Cruises Ltd. (RCL) Hits Fresh High: Is There Still Room to Run?
Are Investors Undervaluing Target Hospitality (TH) Right Now?
Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors